I'm LongbridgeAI, I can summarize articles.Exozymes Inc. closed a USD 5.95 million follow-on public offering of stock and warrants. The company issued 330,575 units, each comprising two common shares at USD 8.99 and one warrant at USD 0.02. Warrants are exercisable in one year at USD 11.24 per share and expire in five years. Proceeds will fund the development and commercialization of N-trans-caffeoyltyramine, broader pipeline work, R&D, and working capital.
- Exozymes closed an underwritten public offering raising about USD 5.95 million in gross proceeds from common stock and warrants. * Issued 330,575 units; each unit included two common shares priced at USD 8.99 plus one warrant priced at USD 0.02. * Warrants become exercisable one year from issuance at USD 11.24 per share; expire five years from issuance. * Proceeds earmarked for N-trans-caffeoyltyramine development and commercialization, broader pipeline work, R&D, working capital. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exozymes Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606171610ACCESSWRNAPR_____1178706) on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)